                         SEQUENCE LISTING

<110>  ASTON UNIVERSITY
       TISDALE, Michael J.
       RUSSELL, Steven
 
<120>  GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC 
       USES THEREOF

<130>  P52504WO/JCH

<150>  US 61/420,677
<151>  2010-12-07

<150>  US 61/384,652
<151>  2010-09-20

<150>  US 61/358,596
<151>  2010-06-25

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  276
<212>  PRT
<213>  Homo sapiens

<400>  1

Gln Glu Asn Gln Asp Gly Arg Tyr Ser Leu Thr Tyr Ile Tyr Thr Gly 
1               5                   10                  15      


Leu Ser Lys His Val Glu Asp Val Pro Ala Phe Gln Ala Leu Gly Ser 
            20                  25                  30          


Leu Asn Asp Leu Gln Phe Phe Arg Tyr Asn Ser Lys Asp Arg Lys Ser 
        35                  40                  45              


Gln Pro Met Gly Leu Trp Arg Gln Val Glu Gly Met Glu Asp Trp Lys 
    50                  55                  60                  


Glu Asp Ser Gln Leu Gln Lys Ala Arg Glu Asp Met Glu Thr Leu Lys 
65                  70                  75                  80  


Asp Ile Val Glu Tyr Tyr Asn Asp Ser Asn Gly Ser His Val Leu Gln 
                85                  90                  95      


Gly Arg Phe Gly Cys Glu Ile Glu Asn Asn Arg Ser Ser Gly Ala Phe 
            100                 105                 110         


Trp Lys Tyr Tyr Tyr Asp Gly Lys Asp Tyr Ile Glu Phe Asn Lys Glu 
        115                 120                 125             


Ile Pro Ala Trp Val Pro Phe Asp Pro Ala Ala Gln Ile Thr Lys Gln 
    130                 135                 140                 


Lys Trp Glu Ala Glu Pro Val Tyr Val Gln Arg Ala Lys Ala Tyr Leu 
145                 150                 155                 160 


Glu Glu Glu Cys Pro Ala Thr Leu Arg Lys Tyr Leu Lys Tyr Ser Lys 
                165                 170                 175     


Asn Ile Leu Asp Arg Gln Asp Pro Pro Ser Val Val Val Thr Ser His 
            180                 185                 190         


Gln Ala Pro Gly Glu Lys Lys Lys Leu Lys Cys Leu Ala Tyr Asp Phe 
        195                 200                 205             


Tyr Pro Gly Lys Ile Asp Val His Trp Thr Arg Ala Gly Gln Val Gln 
    210                 215                 220                 


Glu Pro Glu Leu Arg Gly Asp Val Leu His Asn Gly Asn Gly Thr Tyr 
225                 230                 235                 240 


Gln Ser Trp Val Val Val Ala Val Pro Pro Gln Asp Thr Ala Pro Tyr 
                245                 250                 255     


Ser Cys His Val Gln His Ser Ser Leu Ala Gln Pro Leu Val Val Pro 
            260                 265                 270         


Trp Glu Ala Ser 
        275     


<210>  2
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  2

Lys Lys Val Tyr 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  3

Asp Gly Val Asp 
1               


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  4

Ile Glu Phe Thr Asp 
1               5   


<210>  5
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  5

Asp Glu Val Asp 
1               


<210>  6
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  6

Ile Glu Phe Thr Asp 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct: peptide linker

<400>  7

Gly Gly Gly Gly Ser 
1               5   


